Literature DB >> 20252057

Intravenous administration of iron.

J A NISSIM.   

Abstract

Entities:  

Keywords:  IRON/administration

Mesh:

Substances:

Year:  1947        PMID: 20252057     DOI: 10.1016/s0140-6736(47)90053-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

1.  [Intravenous iron loading as a function test of the RES].

Authors:  I HOPPE; W GOETTE; C DEMKE; E JAHN; K SCHWEIKART; H OVERKAMP
Journal:  Blut       Date:  1961-12

2.  [Colloidal ferrosaccharate therapy].

Authors:  E GISINGER; H VETTER
Journal:  Blut       Date:  1956-10

3.  Iron replacement therapy: entering the new era without misconceptions, but more research is needed.

Authors:  Domenico Girelli; Giacomo Marchi; Fabiana Busti
Journal:  Blood Transfus       Date:  2017-09       Impact factor: 3.443

4.  Parenteral irons versus transfused red blood cells for treatment of anemia during canine experimental bacterial pneumonia.

Authors:  Dante A Suffredini; Wanying Xu; Junfeng Sun; Jesús Barea-Mendoza; Steven B Solomon; Samuel L Brashears; Andreas Perlegas; Daniel B Kim-Shapiro; Harvey G Klein; Charles Natanson; Irene Cortés-Puch
Journal:  Transfusion       Date:  2017-06-27       Impact factor: 3.157

Review 5.  Modern iron replacement therapy: clinical and pathophysiological insights.

Authors:  Domenico Girelli; Sara Ugolini; Fabiana Busti; Giacomo Marchi; Annalisa Castagna
Journal:  Int J Hematol       Date:  2017-12-01       Impact factor: 2.490

6.  Studies on a new intramuscular haematinic for piglet anaemia.

Authors:  K G Högberg; S Lindvali; K Orth; B Thafvelin; K Uthne
Journal:  Acta Vet Scand       Date:  1968       Impact factor: 1.695

Review 7.  Criticality of Surface Characteristics of Intravenous Iron-Carbohydrate Nanoparticle Complexes: Implications for Pharmacokinetics and Pharmacodynamics.

Authors:  Felix Funk; Beat Flühmann; Amy E Barton
Journal:  Int J Mol Sci       Date:  2022-02-15       Impact factor: 6.208

8.  High-Dose Intravenous Iron with Either Ferric Carboxymaltose or Ferric Derisomaltose: A Benefit-Risk Assessment.

Authors:  Johannes M M Boots; Rogier A M Quax
Journal:  Drug Saf       Date:  2022-09-06       Impact factor: 5.228

Review 9.  Commentary: Actions in the pipeline and the way forward to reduce maternal and perinatal mortality in Ethiopia.

Authors:  Yifru Berhan; Asres Berhan
Journal:  Ethiop J Health Sci       Date:  2014-09

10.  Beyond efficacy and safety-the need for convenient and cost-effective iron therapy in health care.

Authors:  Sunil Bhandari
Journal:  NDT Plus       Date:  2011-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.